67. Wu, Y., Jin, M., Fernandez, M., Hart, K.L., Liao, A., Ge, X., Fernandes, S.M., McDonald, T., Chen, Z., Röth, D., Ghoda, L.Y., Marcucci, G., Kalkum, M., Pillai, R.K., Danilov, A.V., Li, J.J., Chen, J., Brown, J.R., Rosen, S.T., Siddiqi, T., Wang, L. (2023). METTL3-mediated m6A modification controls splicing factor abundance and contributes to aggressive CLL. Blood Cancer Discovery 4(3):228-245.